Table 2.

Lipid abnormalities (%) according to ESC guidelines in all patients

	All patients (N = 4,222)	High risk (N = 3,783)a	CVD (N = 2,515)	Diabetes without CVD (N = 785)	SCORE risk ≥5% (N = 483)	SCORE risk <5% (N = 439)
TC not at goal (%)b	66.6	65.7	59.6	71.3	88.4	73.8
LDL-C not at goal (%)c	58.1	58.1	52.7	61.3	83.3	58.7
Low HDL-C [<1.0 (men)/1.2 (women) mmol/L] (%)d	22.7	23.1	24.8	24.0	12.9	18.7
Elevated TG (>1.7 mmol/L) (%)e	47.3	47.5	45.9	54.3	44.6	45.2

^aHigh risk = CVD, diabetes, and/or SCORE risk ≥5%

^bTC ≥5 mmol/L in patients with SCORE risk <5%, and TC ≥4.5 mmol/L in patients with SCORE risk ≥5%, diabetes, and/or CVD. Data on 4,175 patients were available

^cLDL ≥3 mmol/L in patients with SCORE risk <5%, and LDL ≥2.5 mmol/L) in patients with SCORE risk ≥5%, diabetes, and/or CVD. Data 3,887 patients were available

^dData on 3,685 patients were available

^eData on 3,727 patients were available